![Aidan Synnott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aidan Synnott
Directeur Général chez
ONCODESIGN
Profil
Aidan John Synnott is Co-Chief Executive Officer at CRL Group France SAS since 2019.
He is Chief Executive Officer at Oncodesign SA starting in 2025.
He serves as Chairman at Charles River Laboratories France Safety Assessment SAS since 2018 and at Charles River Laboratories Evreux SAS. Formerly, Mr. Synnott was Director at KWS Biotest Ltd.
Postes actifs de Aidan Synnott
| Sociétés | Poste | Début |
|---|---|---|
| ONCODESIGN | Directeur Général | 11/04/2025 |
Charles River Laboratories France Safety Assessment SAS
 Charles River Laboratories France Safety Assessment SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical and natural sciences | Président | 05/07/2018 |
Citoxlab France SAS
 Citoxlab France SAS Miscellaneous Commercial ServicesCommercial Services Operates as a research laboratory | Président | - |
CRL Group France SAS
 CRL Group France SAS Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | 30/05/2019 |
Anciens postes connus de Aidan Synnott
| Sociétés | Poste | Fin |
|---|---|---|
KWS BioTest Ltd.
 KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology Provides preclinical pharmacology and drug development for human diseases | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Citoxlab France SAS
Citoxlab France SAS Miscellaneous Commercial ServicesCommercial Services Operates as a research laboratory | Commercial Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology Provides preclinical pharmacology and drug development for human diseases | Health Technology |
Charles River Laboratories France Safety Assessment SAS
Charles River Laboratories France Safety Assessment SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical and natural sciences | Commercial Services |
CRL Group France SAS
CRL Group France SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
